Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results-Reference-Cited by-同舟云学术

Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results

Published:2014-01-09 Issue:4 Volume:113 Page:623-635
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Roehrborn Claus G.¹,Barkin Jack²,Tubaro Andrea³,Emberton Mark⁴,Wilson Timothy H.⁵,Brotherton Betsy J.⁵,Castro Ramiro⁶

Affiliation:

1. Department of Urology; UT Southwestern Medical Center; Dallas TX USA

2. Department of Urology; University of Toronto; Toronto ON Canada

3. Department of Urology; Sapienza University of Rome; Rome Italy

4. Division of Surgery and Interventional Science; University College London; London UK

5. GlaxoSmithKline; Research Triangle Park NC USA

6. GlaxoSmithKline, R&D; King of Prussia PA USA

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12500/fullpdf

Reference20 articles.

1. Oelke M Bachman A Descazeaud A Guidelines on the management of male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) European Association of Urology Uroweb 2012 http://www.uroweb.org/gls/pdf/12_Male_LUTS_LR%20May%209th%202012.pdf

2. JUA clinical guidelines for benign prostatic hyperplasia;Homma;Int J Urol,2011

3. NICE CG97 Lower urinary tract symptoms: NICE guideline 2010 http://guidance.nice.org.uk/CG97

4. 2010 Update: guidelines for the management of benign prostatic hyperplasia;Nickel;Can Urol Assoc J,2010

5. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater;Kaplan;J Urol,2006

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of medical treatment on storage and voiding LUTS, nocturia, and quality of life in men at risk for progression;Prostate Cancer and Prostatic Diseases;2023-12-01

2. Urinary incontinence - medication versus surgery;Urologie pro praxi;2023-03-21

3. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

4. COMPARISON OF EFFICACY OF TAMSULOSIN, ALFUZOSIN, AND SILODOSIN IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA;Asian Journal of Pharmaceutical and Clinical Research;2023-02-07

5. Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression;European Urology Focus;2023-01